炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 为促进永赢国证商用卫星通信产业交易型开放式指数证券投资基金（以下简称：卫星ETF）的市场流动 性和平稳运行，根据《深圳证券交易所证券投资基金业务指引第2号一一流动性服务》等有关规定，自 2026年2月6日起，本公司新增国泰海通证券股份有限公司为卫星ETF（代码：159206）的流动性服务 商。 特此公告。 为促进永赢中证港股通医疗主题交易型开放式指数证券投资基金（以下简称：港股医疗ETF永赢）的市 场流动性和平稳运行，根据《深圳证券交易所证券投资基金业务指引第2号一一流动性服务》等有关规 定，自2026年2月6日起，本公司新增国泰海通证券股份有限公司为港股医疗ETF永赢（代码：159366） 的流动性服务商。 特此公告。 2026年2月6日 2026年2月6日 关于永赢中证港股通医疗主题交易型开放式指数证券 投资基金新增流动性服务商的公告 永赢基金管理有限公司 永赢基金管理有限公司 ...

证券代码：601881 证券简称：中国银河 公告编号：2026-014 中国银河证券股份有限公司 中国银河证券股份有限公司（以下简称"本公司"）于2025年10月15日成功发行了中国银河证券股份有限 公司2025年度第二十四期短期融资券（以下简称"本期短期融资券"），本期短期融资券发行额为人民币 40亿元，票面利率为1.66%，短期融资券期限为112天，兑付日期为2026年2月4日。（详见本公司于 2025年10月16日刊登于上海证券交易所网站（www.sse.com.cn）的《中国银河证券股份有限公司2025年 度第二十四期短期融资券发行结果公告》）。 2026年2月4日，本公司兑付了本期短期融资券本息共计人民币4,020,374,794.52元。 特此公告。 中国银河证券股份有限公司董事会 2026年2月6日 2025年度第二十四期短期融资券兑付完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603699 证券简称：纽威股份 公告编号：临2026-002 苏州纽威阀门股份有限公司 关于控股股东权益变动触及1%刻度的提示性公告 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： ■ 一、信息披露义务人及其一致行动人的基本信息 1.身份类别 ■ 2.信息披露义务人信息 ■ 3.一致行动人信息 控股股东及其一致行动人保证向本公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 ■ 二、权益变动触及1%刻度的基本情况 公司于2026年2月5日收到控股股东席超先生的通知，2026年1月12日至2026年2月5日期间，席超先生通 过集中竞价方式累计减持公司5,598,723股A股股票，占公司当前总股本的0.72%。本次权益变动后，其 与一致行动人合计持有公司股份比例由减持计划公告时的62.70%减少至当前总股本的62.00%，权益变 动触及1%刻度，具体情况如下： ■ 注1：公司于2026年1月23日对2023年限制性股票激励计划部分激励对象已获授但尚未解除限售的合计 243,228股限制性股票进行回 ...

Summary of Key Points Core Viewpoint - Shanxi Meijin Energy Co., Ltd. has provided guarantees for its subsidiaries and associated companies, exceeding 50% of its latest audited net assets, which may pose potential risks for investors [1]. Group 1: Guarantee Overview - The company’s subsidiary, Shanxi Meijin Huasheng Chemical New Materials Co., Ltd., has applied for a credit limit of 50 million RMB from CITIC Bank, with the company providing a joint liability guarantee for three years [2]. - Qingxu Hongbo Sewage Treatment Co., Ltd., a joint venture of Huasheng Chemical, has applied for a credit limit of 100 million RMB from China Everbright Bank, with Huasheng Chemical guaranteeing 40% of this amount, equating to a maximum guarantee of 40 million RMB for three years [2]. Group 2: Approval and Financial Limits - The company’s first extraordinary shareholders' meeting in 2026 approved a total guarantee limit of up to 4 billion RMB for its subsidiaries, allowing them to apply for loans or financing within this limit [3]. - The shareholders' meeting also approved a guarantee for Huasheng Chemical to support Qingxu Hongbo's financing, with a maximum financing balance of 300 million RMB and a guarantee balance of 120 million RMB [3]. Group 3: Financial Status of Guaranteed Entities - As of December 31, 2024, Huasheng Chemical reported total assets of approximately 1.26 billion RMB, total liabilities of about 939.53 million RMB, and a net asset of approximately 317.24 million RMB, with a net loss of about 39.26 million RMB for the year [6]. - Qingxu Hongbo reported total assets of approximately 57.70 million RMB and a net asset of about 28.61 million RMB as of December 31, 2024, with a net loss of approximately 3.91 million RMB for the year [9]. Group 4: Board of Directors' Opinion - The board believes that the guarantees are necessary to meet the funding needs of the subsidiaries and are in line with the overall interests of the listed company, asserting that the financial structure of the guaranteed entities is healthy and the risks are controllable [11]. - The company has no overdue guarantees or legal disputes related to the guarantees provided [11]. Group 5: Total Guarantee Amounts - After the recent guarantees, the remaining approved guarantee limit for subsidiaries is approximately 395 million RMB, with total guarantees to subsidiaries and associated companies amounting to about 727.16 million RMB, representing 50.32% of the latest audited net assets [11].

Core Viewpoint - The company, Bona Film Group Co., Ltd., has announced its expected related party transactions for the year 2026, which are deemed necessary for its normal business operations and have been approved by the board of directors [2][3][13]. Group 1: Overview of Related Party Transactions - The company anticipates a total of RMB 62 million in related party procurement transactions and RMB 92.2 million in related party sales transactions with Zhejiang Dongyang Dama Entertainment Co., Ltd. for 2026 [2]. - The company expects to pay RMB 22 million in investment to Shanghai Tingdong Film Co., Ltd. and receive RMB 45 million from film revenue sharing [2]. Group 2: Board Approval Process - The expected related party transaction amounts were reviewed and unanimously approved by the independent directors at a special meeting prior to the board meeting [3][14]. - The board meeting held on February 4, 2026, resulted in a vote of 5 in favor, 2 abstentions, and no opposition, confirming the proposal for related party transactions [3][21]. Group 3: Nature and Purpose of Transactions - The related party transactions are conducted based on fair market principles and are necessary for the company's daily operations, ensuring no harm to the interests of the company or its minority shareholders [9][11][13]. - The company maintains independence in its operations, and these transactions will not affect its independence or create dependency on related parties [12][13].

Meeting Overview - The first extraordinary general meeting of shareholders for 2026 was held on February 5, 2026, at 14:30, combining both on-site and online voting methods [2][3] - The meeting was presided over by the chairman, Mr. Chen Sheng, and complied with relevant laws and regulations [3][10] Attendance - A total of 205 shareholders attended the meeting, representing 37,147,263 shares, which is 5.9730% of the total voting shares [4][5] - Among them, 2 shareholders attended in person, representing 14,800 shares (0.0024%), while 203 shareholders participated via online voting, representing 37,132,463 shares (5.9706%) [4][5] Voting Results - The proposal regarding the expected daily related transactions for 2026 was approved, with 34,922,902 shares in favor (94.0120%), 2,059,361 shares against (5.5438%), and 165,000 shares abstaining (0.4442%) [9] - The related shareholder, Nanjing New Industry Investment Group Co., Ltd., abstained from voting on this proposal, holding 259,390,380 shares [8] Legal Opinion - The legal opinion provided by Jiangsu Taihe Law Firm confirmed that the meeting's procedures and voting results were in compliance with applicable laws and regulations [10]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600644 证券简称：乐山电力 公告编号：2026-009 乐山电力股份有限公司 第十一届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 乐山电力股份有限公司（简称"公司"）于2026年2月5日召开2026年第一次临时股东会，会议选举产生了 公司第十一届董事会非独立董事和独立董事，上述人员与公司职工代表大会选举产生的职工董事贾海燕 （详见《乐山电力股份有限公司关于选举职工董事的公告》（公告编号：2026-005））共同组成公司第 十一届董事会。股东会结束后，公司以口头方式向董事发出了召开公司第十一届董事会第一次会议的通 知。公司第十一届董事会第一次会议于2026年2月5日在乐山市金海棠大酒店会议室以现场与视频会议系 统相结合的方式召开，应出席会议董事11名，现场出席会议董事9名，通过视频会议系统出席会议董事2 名，董事林晓华、乔一桐通过视频会议系统出席会议，全体与会董事一致同意推选何明主持本次会议， 公司高级管理人员 ...

证券代码：600211 证券简称：西藏药业 公告编号：2026-005 西藏诺迪康药业股份有限公司 关于控股子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 担保对象及基本情况 二、被担保人基本情况 （一）锐正苏州基本情况 ■■ 三、担保协议的主要内容 本次授信及担保事项需得到相关金融机构审核同意，目前尚未签署相关协议，具体内容以实际签署的协 议为准。 四、担保的必要性和合理性 ■ 注：上述"实际为其提供的担保余额"为本公司控股子公司Accuredit Therapeutics Limited下属全资子公司 Accuredit Therapeutics Hongkong Limited为锐正苏州提供。 ● 累计担保情况 ■ 一、担保情况概述 为满足本公司控股子公司Accuredit Therapeutics Limited（本公司及一致行动人合计持有51.02%股份）下 属的全资孙公司锐正上海及其通过VIE架构协议控制的锐正苏州的经营、研发投入资金需求，Accuredit Therape ...

Transaction Overview - The company plans to acquire 38% equity of Boke Guoxin (Wuhan) Technology Co., Ltd. for a total consideration of RMB 73.71 million, distributed among four sellers [2][4][17] - After the transaction, the company's ownership in the target company will increase from 32% to 70%, making it a subsidiary included in the consolidated financial statements [2][4][36] - This acquisition is a strategic move to enhance the company's capabilities in automation hardware, software platforms, and medical AI applications, promoting a comprehensive integration of products and solutions [4][5][35] Financial Details - The target company achieved an unaudited net profit of RMB 14.33 million in 2025, leading to an overall valuation of RMB 194 million based on a price-to-earnings (PE) ratio of 13.54 [12][15] - The acquisition price reflects a significant premium over the target company's net assets, with a net asset appreciation rate of 200.13% [15][36] Strategic Implications - The acquisition is expected to enhance the company's market competitiveness by integrating its existing products with the target company's AI solutions, thereby creating a more comprehensive smart hospital solution [5][35] - The target company is a member of the China Healthcare Information Interoperability Technology Alliance and has experience with international healthcare standards, which will aid in expanding the company's overseas market presence [5][35] Approval and Compliance - The transaction was approved by the company's board on February 5, 2026, and does not require shareholder approval as it does not constitute a related party transaction or a major asset restructuring [3][6][35] - The transaction is subject to various regulatory approvals and the signing of a share transfer agreement, which has not yet occurred [3][6][35] Management and Operational Changes - Post-acquisition, the target company's board will be restructured, with the company's representatives holding a majority of the board seats, and the chairman will be the company's actual controller [37][36] - The transaction does not involve any personnel changes or land leasing issues within the target company [37][36]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301366 证券简称：一博科技 公告编号：2026-002 深圳市一博科技股份有限公司 关于取得发明专利证书的公告 深圳市一博科技股份有限公司（以下简称公司）于近日取得由国家知识产权局颁发的发明专利证书，具 体情况如下： 一、发明专利证书基本情况 1、发明专利证书（第8637362号） 发明名称：一种印制电路板器件封装位号自动排列的方法 专利权人：深圳市一博科技股份有限公司 发 明 人：明睿；王灿钟 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 专 利 号： ZL 2022 1 0235335.6 申请日期：2022年03月10日 授权公告日：2026年01月09日 授权公告号：CN 114647997 B 本发明公开了一种印制电路板器件封装位号自动排列的方法，有助于大量减少设计人员的工作量，提高 工作效率，减少工作误差。 2、发明专利证书（第8638218号） 发明名称：一种时序信号印制线路径成锐角的检查方法 专利权人：深圳市一博科技股份有限公司 发 明 人：明睿；王灿钟 专 利 号： ZL 2 ...